Long-term clinical and ultrasonographic evaluation of thrombophilic patients with deep venous thrombosis
Viviane Alessandra Capelluppi Tófano; Francisco Humberto Abreu Maffei; Hamilton Almeida Rollo; Marcone Lima Sobreira; Carlos Roberto Padovani; Isolete Tomazini Aparecida Santos
Abstract
Keywords
References
Maffei FHA, Rollo HA. Trombose venosa profunda dos membros inferiores: incidência, patologia, fisiopatologia e diagnóstico. Doenças vasculares periféricas. 2002:1363-86.
Castro Silva M. Venous thromboembolism in the State of Minas Gerais and its projection to Brazil: Study based in 2,331,353 hospitalizations. Intern Angiol. 1997;16:193-6.
McLafferty RB, Lohr JM, Caprini JA. Results of the national pilot screening program for venous disease by the American Venous Forum. J Vasc Surg. 2007;45:142-8.
Geerts WH, Bergqvist D, Pineo GF. Prevention of Venous Thromboembolism. Chest. 2008;133:381S-453S.
Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353(9159):1167-73.
Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet.. 2001;109:369-84.
Pomp ER, Cessie S, Rosendaal FR, Doggen CJM. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol. 2007;139:289-96.
D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood. 1997;90:1-11.
Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations and the risk of venous thrombosis. JAMA. 2005;293:715-22.
Bank I, Middeldorp S, Büller HR. Hereditary and acquired thrombophilia. Semin Respir Crit Care Med. 2000;21:483-91.
Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222-9.
Dahlbäck B. Resistance to activated protein C caused by the R 506 Q mutation in the gene for factor V is a common risk factor for venous thrombosis. J Intern Med Suppl. 1997;242(740):1-8.
Pieroni F, Lourenço DM, Morelli VM, Maffei FH, Zago MA, Franco RF. Cytokine gene variants and venous thrombotic risk in the BRATROS (Brazilian Thrombosis Study). Thromb Res. 2007;120(2):221-9.
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-Untranslated region of prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-703.
Morelli V, Lourenço DM, D'Almeida V. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis. 2002;13:271-5.
Pereira AC, Lourenço D, Maffei FH. A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study). Thromb Res. 2007;119:183-8.
Graves M. Antiphosfolipid antibodies and thrombosis. Lancet. 1999;353:1348-53.
Genoud V, Castañon M, Annichino-Bizzacchi J, Korin J, Kordich L. Prevalence of three prothrombotic polymorphisms: fator V G1691A, fator II G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T in Argentina. Thromb Res. 2000;100:127-31.
Vossen C, Walker I, Svensson P. Recurrence rate after venous thrombosis in patients with familial thrombophilia. J Vasc Biol.. 2005;25:1992-7.
Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol. 2009;145(3):286-95.
Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease. Chest. 2008;133:454S-545S.
Spiezia L, Campello E, Giolo E, Villalta S, Prandoni P. Thrombophilia and the risk of post-thrombotic syndrome: retrospective cohort observation. J ThrombHaemost. 2010;8:211-3.
Labropoulos N, Tiongson J, Pryior L. Definition of venous reflux in lower-extremity veins. J Vasc Surg. 2003;38:793-8.
Wilson W, Guaravi AE, Koike T. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an International Workshop. Arthritis Rheum. 1999;42:1309-11.
Goodman LA. Simultaneous confidence intervals for contrasts among multinomial populations. Ann Math Stat. 1964;35:716-25.
Goodman LA. On simultaneous confidence intervals for multinomial proportions. Technometrics. 1965;7:247-54.
Zar JH. Bioestatistical analysis. 1999.
Norman GR, Streiner DL. Bioestatistics - the bare essentials. 1994.
Brower JL, Veeger NJGM, Kluin-Nelemans HC, Van der Meer J. The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Ann Intern Med.. 2006;145:807-15.
Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors and recurrent venous thrombotic events. JAMA. 2005;293:2352-61.
Miyakis S, Lockshin MD, Atsumi T. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb. Haemost.. 2006;4:295-306.
Azem F, Many A, Yovel I, Amit A, Lessing JB, Kupfermine MJ. Increase rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19:368-70.
Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. Arch Intern Med. 2004;164:558-63.
Pabinger R, Vormittag R. Thrombophilia and pregnancy outcomes. J Throm Haemost. 2005;3:1603-10.
Souza SS, Ferriani RA, Pontes AG, Zago MA, Franco RF. Factor V Leiden and factor II G20210A mutations in patients with recurrent abortion. Hum Reprod. 1999;14:2448.
Rai R. Obstetrical management of antiphospholipid syndrome. J Autoinmun. 2000;15:203-7.
Lijfering WM, Brower JLP, Veeger NJGM. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113:5314-22.
Tosetto A, Rodeghiero F, Martinelli I. Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation. Br J Haematol. 1998;103:8-50.
Martinelli I, Battaglioni T, Razzari C, Mannucci M. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia. J Throm Haemost. 2007;5:98-101.
Prandoni P, Lensing AWA, Cogo A. The long-term clinical course of deep venous thrombosis. Ann Intern Med. 1996;125:1-7.
Brandjes DP, Baller HR, Heijboer H. Randomised trial of effect of compression stocking in patients with symptomatic proxinal-vein thrombosis. Lancet. 1997;349:759-62.
Kahn SR, Solymoss S, Lamping DL, Abenhaim L. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med. 2000;15:425-9.
Kahn SR, Kearon C, Julian JA. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost. 2005;3:718-23.
Pesavento R, Bernardi E, Concolato A, Dalla Vale F, Pagnan A, Prandoni P. Posstthrombotic syndrome. Semin Thromb Hemost. 2006;32:744-51.